Legal & General Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
77,296
+5,010
| +7% | +$80.2K | ﹤0.01% | 2170 |
|
|
2025
Q1 | $1.24M | Buy |
72,286
+13,296
| +23% | +$227K | ﹤0.01% | 2102 |
|
|
2024
Q4 | $1.46M | Buy |
58,990
+3,596
| +6% | +$89.1K | ﹤0.01% | 2112 |
|
|
2024
Q3 | $1.58M | Buy |
55,394
+1,410
| +3% | +$40.2K | ﹤0.01% | 2069 |
|
|
2024
Q2 | $1.43M | Buy |
53,984
+718
| +1% | +$19K | ﹤0.01% | 2074 |
|
|
2024
Q1 | $1.72M | Sell |
53,266
-222
| -0.4% | -$7.17K | ﹤0.01% | 1996 |
|
|
2023
Q4 | $2.25M | Sell |
53,488
-5,820
| -10% | -$245K | ﹤0.01% | 1889 |
|
|
2023
Q3 | $2.28M | Buy |
59,308
+8,530
| +17% | +$327K | ﹤0.01% | 1841 |
|
|
2023
Q2 | $963K | Buy |
50,778
+35,712
| +237% | +$677K | ﹤0.01% | 2237 |
|
|
2023
Q1 | $234K | Buy |
15,066
+867
| +6% | +$13.4K | ﹤0.01% | 2528 |
|
|
2022
Q4 | $252K | Hold |
14,199
| – | – | ﹤0.01% | 2523 |
|
|
2022
Q3 | $80K | Sell |
14,199
-14,860
| -51% | -$83.7K | ﹤0.01% | 2879 |
|
|
2022
Q2 | $113K | Sell |
29,059
-775
| -3% | -$3.01K | ﹤0.01% | 2824 |
|
|
2022
Q1 | $164K | Buy |
29,834
+141
| +0.5% | +$775 | ﹤0.01% | 2732 |
|
|
2021
Q4 | $253K | Buy |
29,693
+1,637
| +6% | +$13.9K | ﹤0.01% | 2619 |
|
|
2021
Q3 | $244K | Buy |
28,056
+7,071
| +34% | +$61.5K | ﹤0.01% | 2623 |
|
|
2021
Q2 | $222K | Sell |
20,985
-864
| -4% | -$9.14K | ﹤0.01% | 2508 |
|
|
2021
Q1 | $351K | Buy |
21,849
+16,288
| +293% | +$262K | ﹤0.01% | 2358 |
|
|
2020
Q4 | $258K | Sell |
5,561
-272
| -5% | -$12.6K | ﹤0.01% | 2370 |
|
|
2020
Q3 | $206K | Buy |
5,833
+1,685
| +41% | +$59.5K | ﹤0.01% | 2352 |
|
|
2020
Q2 | $101K | Buy |
+4,148
| New | +$101K | ﹤0.01% | 2527 |
|